186 studies on Mgf curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Simple Peptide | 3 | 99.64% | View COA → |
| Alpha & Omega | 3 | 99.64% | View COA → |
Recent certificates: #15169 (99.491%) · #46295 (99.873%) · #24549 (99.493%) · #45764 (99.614%) · #60659 (99.25%) · #62569 (99.25%)
Manufacturers with published third-party certificates of analysis for Mgf. Open a vendor to see every batch we've verified.
This study provides compelling evidence that **incorporating IGF-1 levels into clinical evaluations can significantly improve risk stratification for MASLD patients**, particularly concerning their cardio-kidney healt…
IMC-A12's safety and optimal dosing are being evaluated in participants with advanced tumors resistant to current therapies.
While specific findings are not available from this abstract, the study's objective highlights a critical need for novel therapies in **hyperinsulinism**. **Recombinant human IGF-I** represents a promising avenue, pot…
GH administration in healthy volunteers boosted mean GH levels by **46%** and IGF-I levels by **45%**, with basal GH increasing **7.5-fold**.
An open-label RCT will investigate how varying **Growth Hormone** doses, targeting different IGF-I levels, impact cardiovascular risk factors in **GHD** adults.
Washed microbiota transplantation (WMT) is under investigation as a novel therapeutic approach for **food intolerance (FI)**, a common non-immune adverse food reaction affecting 20% of the global population.
**Real-world data from national registries are critical for understanding the long-term impact of somatropin therapy in diverse patient populations.** This registry provides a framework to monitor the effectiveness an…
**Identifying natural, well-tolerated agents for breast cancer prevention is crucial**, especially for high-risk postmenopausal women seeking alternatives to pharmaceutical interventions. If green tea extract demonstr…
This study's findings, once available, could significantly advance our understanding of personalized treatment approaches for **Major Depressive Disorder**. If the antidepressant efficacy of **JNJ-42847922** is indeed…
Study evaluates 5g oral **L-arginine** daily for 14 days on microcirculation and muscle health in older women with sarcopenia or T2DM.
Establishing the efficacy and safety of **recombinant human growth hormone** within the Korean population affected by **idiopathic short stature** is paramount for optimizing clinical management. Positive findings fro…
If combined training proves superior, it could significantly reshape **post-stroke rehabilitation protocols**, offering a more effective strategy for improving patient outcomes. This would mean moving beyond tradition…
Increlex (IGF-1) is proposed to address growth failure in children with chronic liver disease, a condition resistant to traditional growth hormone therapy.
SAGIT® instrument validation study aims to define and validate its scoring for managing **acromegaly** patients and disease activity.
The GH/IGF-1 axis is crucial for bone health, with growth hormone and its secretagogues influencing bone development and maintenance.
While the abstract does not present specific findings, the *aim* of this research highlights the critical need for improved prognostic biomarkers in **intracerebral hemorrhage (ICH)**. If future full publications from…
ACRODAT® software, using 5 key parameters, is undergoing prospective evaluation to determine if it improves acromegaly treatment outcomes.
If this study demonstrates that a **low-glycemic-load and milk-free diet significantly reduces acne severity**, it could offer a powerful, non-pharmacological intervention for individuals struggling with **acne**. Thi…
A randomized, double-blinded, placebo-controlled study will evaluate Premium Revitalizing Elixir containing IGF-1, FGF-7, caffeine, and panthenol for scalp care efficacy in 60 adults with hair thinning.
The severe **bone loss** associated with **anorexia nervosa** represents a critical unmet medical need, often leading to irreversible skeletal damage. If this trial demonstrates that **DHEA** and **estrogen replacemen…
Low-dose growth hormone was hypothesized to reduce visceral fat in HIV lipodystrophy patients, with secondary endpoints including IGF-1, glucose, and lipids.
While this specific trial yielded no data due to its withdrawal, the underlying clinical question remains highly relevant for patients with **acromegaly**. Identifying more effective or alternative somatostatin analog…
A successful once-weekly growth hormone therapy like somapacitan could significantly **reduce the treatment burden for children with GHD and their caregivers**, potentially leading to improved adherence and better lon…
A double-blinded RCT will investigate if **PEMF treatment** can reduce pain and improve knee function in older adults with **knee osteoarthritis**.
PF-05231023's safety, tolerability, pharmacokinetics, and pharmacodynamics were assessed in a Phase 1 study in adult subjects with **Type 2 Diabetes**.
Understanding the role of **IGF-I in mitigating HIV metabolic disease** could offer a novel therapeutic avenue for a challenging patient population. If IGF-I proves effective in improving body composition, glucose con…
Phase 3 study initiated to determine optimal dose, safety, and efficacy of **PEG-somatropin** injection for children with **Turner Syndrome**.
If successful, this study could introduce a new therapeutic option for **acromegaly** patients who struggle to achieve or maintain `IGF-1` normalization with existing somatostatin analogs. A novel somatostatin analog …
Enteral zinc supplementation is hypothesized to improve growth in infants at risk for bronchopulmonary dysplasia, potentially addressing persistent growth deficits.
A novel static affinity chromatography strategy was developed to isolate a **cod bone calcium-binding peptide**, enabling evaluation of its chelation mechanism and calcium transport.
While specific results are not detailed in this abstract, the investigation of **ACP-001 (TransCon hGH)** represents a crucial step towards improving **GHD** treatment. If successful, a once-weekly growth hormone coul…
Lanreotide Autogel 120mg at 28, 42, or 56-day intervals was evaluated for efficacy and safety in acromegaly patients, compared to previous octreotide LAR.
A Phase 3 extension study evaluated the long-term safety and effectiveness of mecasermin (rhIGF-1) in children with severe Primary IGF-1 Deficiency.
If successful, this trial could establish **progressive resistance training** as a crucial non-pharmacological intervention for managing **mild cognitive impairment (MCI)**, potentially delaying its progression to dem…
A pilot study evaluates an **Apulian Lens Culinaris**-based supplement for reducing **sarcopenia**, uremic toxins, and inflammation in dialysis patients.
This study, once completed and published, holds significant implications for pediatric nutrition and public health. If positive, the findings could **inform new dietary guidelines for children**, potentially recommend…
This defined screening protocol offers a crucial framework for **systematic identification of acromegaly** in patients with pre-existing somatic disorders, particularly those with conditions like **type 2 diabetes**. …
A planned Framingham State Food Study will evaluate how dietary composition influences energy expenditure and chronic disease risk factors, aiming to inform nutritional recommendations.
**Clomiphene citrate**'s effect on serum `IGF-1` and testosterone is being assessed in male **acromegaly** patients whose condition remains uncontrolled by conventional treatments.
Understanding the precise dynamics of the **growth hormone axis** in progressive **Nonalcoholic Fatty Liver Disease** (NAFLD) could reveal critical biomarkers for disease severity or progression. If the hypothesized r…
A study will assess somatropin's efficacy in treating **Growth Hormone Deficiency (GHD)** in adults following head injury or major trauma, and determine prevalence.
**Investigating growth hormone axis dysfunction in fibromyalgia is crucial for identifying novel therapeutic targets beyond symptomatic relief.** If r-hGH proves effective, it could offer a physiological approach to m…
A prospective cohort aims to estimate how parenteral nutrition cessation timing and IGF-1 influence growth in very low birth weight infants.
Understanding the contribution of **insulin signaling** to motor neuron reinnervation in **ALS** could unlock entirely new therapeutic strategies. If successful, this research may identify novel targets beyond current…
If a **HIIT program** proves effective, it could offer a highly accessible and non-pharmacological strategy to significantly improve **quality of life**, **executive functions**, and **IGF-1** levels in sedentary youn…
If the hypothesis regarding altered **PRF growth factor** release in **diabetic patients** with **chronic periodontitis** is substantiated, it would fundamentally change how regenerative dental procedures are approach…
**Targeting the `IGF-1R` pathway represents a significant strategy for improving outcomes in advanced `NSCLC`**, a disease with high unmet medical need. If **CP-751,871** demonstrated a survival benefit, it could pave…
**If successful, this trial could establish creatine and resistance training as evidence-based, non-pharmacological interventions for mild cognitive impairment.** This would offer accessible strategies to potentially …
**Combining targeted therapies with traditional chemotherapy** represents a promising strategy to improve patient outcomes in **advanced non-hematologic malignancies**. If **CP-751,871** can safely enhance docetaxel's…
A 6-week single-arm trial will investigate time-restricted feeding's impact on endocrine and metabolic profiles in overweight women with **Polycystic Ovary Syndrome (PCOS)**.
Free, no account — handy when you're working with Mgf.